evolcSign inStart free
Menu

Peptone

Drug discovery platform designing small-molecule candidates for hard-to-treat cancers and neurodegenerative disease targets

Mansfield, United KingdomFounded 2018peptone.ioWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-27

About Peptone

Peptone builds a Product Engine that measures and models intrinsically disordered proteins and uses the results to design small-molecule drug candidates. The engine combines measured ensemble biology, experimental physics, AI and computation, and translational work.

The company's stated focus is hard-to-treat cancers, with programmes listed for metastatic castration-resistant prostate cancer (AR-NTD), MYC-driven solid tumours (c-Myc) and TDP-43 proteinopathy in ALS and frontotemporal dementia. Its pipeline is organised around these targets. Backers listed on the site include F-Prime Capital, Bessemer Venture Partners, Hoxton Ventures, Walden Catalyst, the Banga Family Trust and Taplow Blue Capital.

The company is registered in the United Kingdom, with its registered seat in Mansfield. The website also lists offices in Bellinzona, Switzerland, and San Francisco, USA. Founded in 2018. The website states that it is not currently advertising vacancies.

Product: Product Engine that designs small-molecule drug candidates against intrinsically disordered proteins

Jobs at Peptone

No open positions listed right now.

Leadership

More biotech & pharma companies

  • Petagene

    Genomic data compression, cloud access and encryption software for genomics researchers and bioinformatics teams
    Cambridge, United KingdomBiotech & pharmaFounded 20161 open job
    New on Evolc

  • Pheno Therapeutics

    Develops GPR17-targeting neuroprotective therapeutics for patients with multiple sclerosis and other neurological disorders
    Edinburgh, United KingdomBiotech & pharmaFounded 2018
    New on Evolc

  • Phoremost

    Biotech developing oral small-molecule cancer drugs, lead programme PMC-001 for primary and metastatic brain cancers
    Cambridge, United KingdomBiotech & pharmaFounded 2014
    New on Evolc

  • Phynova Group

    Develops plant-derived health ingredients, including Reducose for blood glucose, for supplement, food and beverage makers
    Banbury, United KingdomBiotech & pharmaFounded 2004
    New on Evolc

  • Plaquetec

    Coronary artery disease endotyping and biomarker discovery for drug developers, using in-vivo plaque sampling
    Cambridge, United KingdomBiotech & pharmaFounded 2007
    New on Evolc

  • Plethora Solutions

    Speciality pharma developing and marketing urology treatments, led by an EU-authorised drug for premature ejaculation
    Chalgrove, United KingdomBiotech & pharmaFounded 2003
    New on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • AWS